Keyora Hydrolysed Collagen Tripeptide: Triple-Pathway Collagen Tripeptide Intervention in Dermal Aging
Framework & Rationale
This project is based on the Keyora Triple-Pathway Collagen Framework, a comprehensive oral dermal intervention model that integrates structural signaling and substrate supply, elastic-network repair, and barrier–hydration–antioxidant defense.
The rationale is that dermal aging is multi-factorial: collagen depletion, elastin fragmentation, extracellular matrix (ECM) collapse, barrier lipid insufficiency, and oxidative imbalance occur simultaneously.
A successful strategy must therefore be multi-mechanistic, not single-target.
Core Advantages and Mechanistic Highlights
1. Structural signaling & substrate supply - Collagen Tripeptides (1,500 mg/day)
- CTP profile advantage:
CTP ≥ 30%; Gly-Pro-Hyp–rich (Gly+Pro+Hyp ≥ 50%); Pro/Hyp 12–15%.
- Why it matters:
These specific tripeptides are highly bioavailable (molecular weight ≈ 500–1,500 Da) and absorbed intact via peptide transporters.
They act as both substrates for collagen biosynthesis and signals to fibroblasts, upregulating collagen, elastin, and hyaluronic acid gene expression.
- Clinical value:
Proven reductions in wrinkle depth, enhanced elasticity, and improved skin smoothness at relatively low doses, avoiding the high-dosage burden of conventional collagen powders.
2. Elastic-network repair - Fish cardiac bulb–derived elastin peptides (20 mg/day)
- Unique feature:
These peptides retain tropo-elastin core motifs with high recognition by dermal fibroblasts.
- Mechanistic advantage:
They upregulate elastin, fibrillin, and lysyl oxidase (LOX), enabling elastic fiber reconstruction, something collagen peptides alone cannot achieve.
- Clinical value:
Restores skin recoil and firmness, directly addressing sagging and loss of resilience - a dimension often missing in collagen-only interventions.
3. Barrier restoration - Ceramide NP 99.5% (2 mg/day)
- Purity advantage:
Nearly pure (≥ 99.5%) NP form, identical to human skin Ceramide-3.
- Mechanistic advantage:
Integrates seamlessly into stratum corneum lamellar bilayers with cholesterol and fatty acids (optimal 3:1:1 ratio), reinforcing the barrier and reducing transepidermal water loss (TEWL).
- Clinical value:
Even at micro-doses, restores barrier integrity, reduces sensitivity, and enhances tolerance - achieving high efficacy with minimal systemic load.
4. Hydration & ECM filling - Hyaluronic Acid (400 kDa, 20 mg/day)
- Formulation advantage:
Medium molecular weight (400 kDa) chosen for balanced absorption and function.
- Mechanistic advantage:
Crosses intestinal paracellular routes and is detectable in plasma; stimulates HAS2/3 expression in dermal fibroblasts; integrates into ECM interstices to increase volume and turgor.
- Clinical value:
Enhances dermal hydration and elasticity, reduces dryness and roughness, and provides visible plumping effects.
Integrated Synergy
- Collagen tripeptides initiate fibroblast activation and provide substrates.
- Elastin peptides ensure elastic network reconstruction, complementing collagen.
- Hyaluronic acid restores hydration and volumization, maintaining ECM flexibility.
- Ceramide NP rebuilds the barrier, locking in hydration and protecting new structural gains.
Together, these four interventions form a closed-loop system - from structure to elasticity to hydration and protection - achieving results beyond single-ingredient supplementation.
Clinical Evidence and Consensus
- Collagen Tripeptides:
Multiple RCTs confirm wrinkle reduction and elasticity improvement with ≥1,000 mg/day dosing.
- Elastin peptides:
Demonstrated improvements in elasticity and reduction of sagging when combined with collagen peptides.
- Hyaluronic Acid (400 kDa):
Supported by RCTs showing hydration and wrinkle reduction.
- Ceramide NP:
Systematic reviews highlight oral ceramide’s efficacy in improving skin moisture, barrier integrity, and tolerance.
Consensus:
International nutricosmetic research increasingly supports multi-component, low-dose/high-purity interventions as superior to high-dose single compounds.
The Keyora Triple-Pathway Framework reflects this consensus, providing a scientifically rational, clinically validated model for oral skin health.
Significance
This project establishes a next-generation nutricosmetic model that prioritizes:
- Mechanistic completeness:
Collagen, elastin, ECM, barrier, hydration, and antioxidant defense addressed simultaneously.
- Bioavailability & purity:
Selection of peptide forms, 400 kDa HA, and 99.5% ceramide NP ensures optimal absorption and activity.
- Synergy, not stacking:
Each component interlocks, creating a continuum of dermal rejuvenation.
- Clinical feasibility:
Low-dose, safe, and sustainable formulation suitable for long-term use.
Background
Skin aging is a multifactorial and progressive process characterized by the loss of dermal collagen, degradation of elastic fibers, extracellular matrix (ECM) disorganization, impaired skin barrier function, reduced hydration, uneven pigmentation, and cumulative oxidative stress.
These changes manifest as fine lines, sagging, dryness, dullness, and increased sensitivity.
While topical interventions remain widely used, their penetration depth is limited, reducing their ability to remodel the dermis at a structural level.
Oral nutricosmetic strategies provide systemic delivery of bioactive compounds that reach the dermis through circulation.
Among these, hydrolyzed collagen tripeptides (HCTPs) demonstrate superior absorption and signaling activity compared with conventional collagen hydrolysates.
When combined with elastin peptides, hyaluronic acid, ceramides, niacinamide, vitamin C, and biotin, HCTPs enable a comprehensive approach to dermal rejuvenation through structural, functional, and nutritional pathways.
Objective
This project, developed within the Keyora Triple-Pathway Collagen Framework, aims to investigate the multi-pathway anti-aging potential of hydrolyzed collagen tripeptides and their synergistic cofactors in oral nutricosmetic interventions.
Specifically, the objective of the Keyora framework is to map the mechanistic pathways through which these bioactives improve fine lines, elasticity, hydration, barrier integrity, skin tone, and resilience against oxidative stress.
Mechanistic Pathways
1. Fine Line Reduction & ECM Activation
Gly–Pro–Hyp and related tripeptides act as both raw substrates and biological signals for fibroblasts, triggering the synthesis of type I collagen and initiating ECM repair.
This contributes to wrinkle reduction and improved dermal density.
2. Elasticity Enhancement
Elastin peptides derived from functional tropoelastin sequences stimulate fibroblast activity, upregulate elastin and fibrillin expression, and reconstruct spring-like elastic fiber networks, restoring firmness and reducing sagging.
3. ECM Remodeling
The structural triad of collagen tripeptides, elastin peptides, and hyaluronic acid synergistically rebuilds dermal scaffolding.
Hyaluronic acid occupies interstitial spaces, enhances hydration, and stabilizes the collagen–elastin matrix, enabling balanced ECM synthesis and degradation.
4. Barrier Repair
Ceramide NP (99.5% purity) and niacinamide enhance epidermal barrier function.
Ceramide replenishes stratum corneum lipids, reduces transepidermal water loss (TEWL), and alleviates sensitivity, while niacinamide stimulates endogenous lipid synthesis and strengthens keratinocyte function.
5. Hydration Support
Medium molecular weight hyaluronic acid (400 kDa) is orally bioavailable, crosses the intestinal barrier, and boosts endogenous hyaluronan synthesis in fibroblasts.
This dual mechanism improves deep hydration and dermal plumpness.
6. Brightening & Tone Regulation
Niacinamide reduces hyperpigmentation by inhibiting melanosome transfer from melanocytes to keratinocytes.
It also enhances skin clarity and counteracts dullness associated with aging.
7. Antioxidant Defense
Vitamin C functions as a cofactor for collagen stabilization, inhibits matrix metalloproteinases, and protects against photoaging by reducing oxidative stress.
Its synergy with collagen tripeptides enhances fibroblast activation and ECM remodeling efficiency.
Synergistic Framework
The intervention can be conceptualized as a 7-in-1 synergistic model:
- Structural Triad: Collagen Tripeptide + Elastin Peptide + Hyaluronic Acid → ECM activation, elasticity restoration, hydration support.
- Functional Duo: Ceramide NP + Niacinamide → Barrier repair and brightening.
- Nutritional Base: Vitamin C + Biotin → Antioxidant defense and lipid metabolism regulation.
This integrative framework ensures multi-level skin rejuvenation, addressing both structural aging (wrinkles, laxity) and functional impairments (dryness, barrier dysfunction, dullness).
Clinical & Preclinical Evidence
1. Clinical trials confirm that orally ingested collagen tripeptides reach plasma intact within 30–60 minutes and activate fibroblasts for ECM synthesis.
2. Elastin peptides have been shown to upregulate elastin and fibrillin expression, improving dermal resilience.
3. Oral hyaluronic acid supplementation (400 kDa) significantly enhances hydration, elasticity, and wrinkle reduction in randomized controlled trials.
4. Ceramide NP demonstrates superior barrier restoration compared with plant-derived precursors, with efficacy at micro-dosing levels (2 mg/day).
5. Niacinamide supplementation improves barrier lipids and reduces hyperpigmentation.
6. Vitamin C serves as an essential antioxidant and cofactor for collagen biosynthesis, while biotin supports lipid metabolism and keratinocyte function.
Together, these findings provide a strong evidence base for the multi-pathway effectiveness of oral collagen tripeptide complexes in skin rejuvenation.
Conclusion & Implications
The integration of hydrolyzed collagen tripeptides with elastin, hyaluronic acid, ceramides, niacinamide, vitamin C, and biotin represents a precision nutrition strategy for comprehensive anti-aging.
By simultaneously addressing ECM activation, elasticity, hydration, barrier repair, pigmentation, and oxidative stress, this multi-dimensional approach offers a scientifically grounded pathway for reversing visible signs of aging and maintaining long-term dermal health.
This project, grounded in the Keyora Triple-Pathway Collagen Framework, underscores the potential of oral nutricosmetics to move beyond single-target approaches by integrating structural signaling, elastic-network repair, and barrier–hydration defense.
The framework provides a scientifically rational foundation for future clinical research and translational applications in dermatology and nutritional science.